Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar jrgyardley (< 20) Submitted: 12/17/2012 6:45:49 PM : Outperform Start Price: $30.83 BMY Score: +51.85

Sector
Patent expirations

Featured Broker Partners


Advertisement